Redbiotec expanding
Redbiotec has rented 200 additional square meters of lab and [...]
Redbiotec closes deal with Roche
Redbiotec closes deal with Roche. Redbiotec AG, the leader in [...]
New purification expert
We are proud to announce that in November 1st Dr. [...]
Redbiotec obtains new grant
Redbiotec obtains a new grant. The grant is a initiative [...]
Redbiotec launches CMV VLP program
Redbiotec has launched the development of several multi-valent virus-like particles [...]
Redbiotec Strengthens its Scientific Advisory Board with Appointments of Professor Dr. Polly Roy and Professor Dr. Rainer Fischer
Redbiotec AG ("Redbiotec" or "the Company"), the leader in protein [...]
V+ invests in Redbiotec
V+ GmbH & Co Fonds 2 KG, a German Venture [...]
Redbiotec’s technology platform raises substantial interest
On the occasion of BioEurope 2009 in Vienna, Europe's most [...]
Successful in vivo test of influenza particles
In Q4 2009 Redbiotec demonstrated a specific immune response of [...]
Implementation of disposable technologies
Redbiotec has successfully implemented novel disposable production technologies into its [...]